Jonathan Goldman

Jonathan Goldman joined Aptuit as Chief Executive Officer in December of 2013. Prior to joining Aptuit, he held several executive positions at ICON Plc, a leading global contract research organization. His tenure at ICON included 3 years as global head of Business Development, as well as senior roles in operations and in medical imaging. He formerly served for 7 years as Chief Medical Officer of Point Biomedical, a development-stage biopharmaceutical company responsible for discovering and developing microsphere-based pharmaceuticals. He currently maintains a Faculty appointment as an Associate Clinical Professor of Medicine in the division of Cardiology at the University of California, San Francisco. Jonathan Goldman Jonathan Goldman Chief Executive Officer Jonathan Goldman joined Aptuit as Chief Executive Officer in December of 2013. Prior to joining Aptuit, he held several executive positions at ICON Plc, a leading global contract research organization. His tenure at ICON included 3 years as global head of Business Development, as well as senior roles in operations and in medical imaging. He formerly served for 7 years as Chief Medical Officer of Point Biomedical, a development-stage biopharmaceutical company responsible for discovering and developing microsphere-based pharmaceuticals. He currently maintains a Faculty appointment as an Associate Clinical Professor of Medicine in the division of Cardiology at the University of California, San Francisco. Jonathan has also recently been awarded an Honorary Fellowship of the Faculty of Pharmaceutical Medicine of the Royal College of Physicians of the United Kingdom. Jonathan has BSc (1986), MBBS (1989) and MD (1995) degrees from the University of London, in addition to Executive MBA qualifications from Columbia University in New York, and the University of California at Berkeley.